News

Discover How D&B Healthcare Insights Transforms Marketing Strategies

Discover How D&B Healthcare Insights Transforms Marketing Strategies

Dun & Bradstreet Launches D&B Healthcare Insights

D&B Healthcare Insights, an add-on to D&B Hoovers, enhances sales and marketing strategies for success in the healthcare market.

Dun & Bradstreet (NYSE: DNB), a world leader in business data and analytics, today unveiled D&B Healthcare Insights. This innovative dataset is tailored specifically to empower sales and marketing teams as they navigate the multifaceted healthcare ecosystem, enabling them to identify growth opportunities and enhance decision-making processes.

What is D&B Healthcare Insights?

D&B Healthcare Insights offers valuable insights into healthcare organizations (HCOs) such as hospitals and clinics, as well as healthcare providers (HCPs). Utilizing the comprehensive platform provided by D&B Hoovers, users can create highly tailored contact lists according to specific healthcare criteria. The ability to filter and organize data based on unique healthcare attributes positions businesses to excel in addressing the needs of the healthcare sector.

Empowering Businesses in Healthcare

Eric Kider, General Manager of Sales & Marketing Solutions at Dun & Bradstreet, expressed that, "Companies aiming to collaborate with healthcare organizations need tailored solutions that provide an in-depth understanding of healthcare intelligence. With D&B Healthcare Insights, we prioritize healthcare, delivering impactful data that allows our clients to uncover new growth paths and establish stronger relationships in the sector. Our extensive expertise amplifies our clients' data-driven decisions, establishing a competitive edge in the market."

Benefits of D&B Healthcare Insights

D&B Healthcare Insights goes beyond simple firmographic data. It serves as a resource for companies in various fields, including life sciences, financial services, insurance, technology, and logistics. Through these insights, organizations can enhance their interactions with healthcare entities to foster meaningful conversations and stimulate customer engagement.

The key advantages of incorporating D&B Healthcare Insights include:

  • Improved Targeting and Segmentation - By understanding business relationships in depth, companies can identify potential markets and refine their territories to enhance data-driven decisions.
  • Identification of New Opportunities - Users can swiftly identify prospects based on criteria aligned with their offerings, ensuring connections with specialized buyers.
  • Enhanced Account-Level Intelligence - The platform provides rich profiles of healthcare organizations, offering detailed insights into their operations.
  • Refined Sales Messaging - Access to current data on healthcare organizations equips sales teams with knowledge necessary for informed discussions, allowing them to address the specific needs of their prospects.

Comprehensive Data for Informed Decisions

Dun & Bradstreet amalgamates its data from over 320 million companies and 485 million contacts with extensive healthcare insights covering 260,000 healthcare entities. This massive database allows for targeted searches based on specific needs, such as organization types, accreditations, bed counts, and other critical metrics, simplifying the process of finding pertinent information.

Healthcare insights mark the initial offering in a series of new datasets that Dun & Bradstreet plans to unveil, reflecting its commitment to evolving its data capabilities to better serve clients across various industries. These enhancements will address the changing landscape in healthcare and beyond.

Moreover, Dun & Bradstreet provides managed Marketing Services to help companies translate these healthcare insights into actionable campaigns. This combination of data and managed services creates a powerful toolkit for businesses striving to succeed in the healthcare space.

About Dun & Bradstreet

Dun & Bradstreet stands as a leader in business decisioning data and analytics, helping companies worldwide improve their performance. The Data Cloud powered by Dun & Bradstreet aids organizations in accelerating revenue, reducing costs, and managing risks effectively. Established in 1841, this esteemed company has a long track record of assisting businesses, regardless of their size, in revealing opportunities and managing risks effectively.

Frequently Asked Questions

What is D&B Healthcare Insights?

D&B Healthcare Insights is a dataset designed to provide sales and marketing teams with critical insights into healthcare organizations and providers.

How does it help businesses?

It aids in improving targeting, identifying new opportunities, and enhancing sales messaging by providing comprehensive healthcare data.

Who can benefit from these insights?

Businesses in life sciences, financial services, insurance, technology, and more can leverage this data to enhance their strategies in the healthcare sector.

What types of data does it include?

The dataset includes information on healthcare organization types, specialties, staff numbers, and operational data to support informed decision-making.

How long has Dun & Bradstreet been operating?

Dun & Bradstreet has been in existence since 1841, offering decades of experience in business data and analytics solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 608

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 23

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 38

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 467

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 187

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 101

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Homebuyers Benefit as Mortgage Rates Hit New Lows

Updated Category News Views 110

Mortgage Rates See a Significant Drop Recent data shows that mortgage rates have fallen to their lowest point in more than 18 months. This presents a prime opportunity for homebuyers who might be thinking about refinancing their current loans. The drop in rates can be linked to various market dynamics, which has led to a noticeable spike in refinancing activity. Current...

Continue Reading
Cross River Bank Launches Innovative FDIC Sweep Service

Updated Category News Views 195

Introducing Cross River's Automated Sweep Feature Cross River Bank, a pioneering technology infrastructure provider known for its innovative embedded financial solutions, has recently unveiled its automated sweep feature leveraging the IntraFi Cash Service. This groundbreaking service allows Cross River's Banking-as-a-Service (BaaS) clients to access enhanced FDIC...

Continue Reading
Understanding P/E Ratio and Its Importance for PNC Investors

Updated Category News Views 198

Understanding the P/E Ratio for PNC Financial Services Group In today’s trading session, PNC Financial Services Group’s stock is valued at $187.43, reflecting a slight increase of 0.87%. Looking at the broader picture, the stock of PNC Financial Services Group Inc. has risen by an impressive 4.19% over the past month and a remarkable 63.74% in the past year. These...

Continue Reading
Grace Therapeutics Sees Positive Outcomes and Business Growth

Updated Category News Views 224

Grace Therapeutics Reports Promising Progress and Financial Update Grace Therapeutics, Inc. (NASDAQ: GRCE), a biopharmaceutical company dedicated to advancing treatment solutions, has just shared significant news regarding its fiscal operations and pivotal clinical advancements. The company focuses on developing GTx-104, a promising injectable formulation of nimodipine...

Continue Reading
Jordan G. Welch's Worship Culture Tour: A Transformative Experience

Updated Category News Views 643

Jordan G. Welch's Worship Culture Tour Unleashes New Dimensions in Worship The Worship Culture Tour is set to launch with a vibrant focus on creating an immersive worship experience that extends beyond traditional confines. This exciting two-day event will guide participants through a journey of spiritual growth across multiple cities, inviting people from all walks of...

Continue Reading